Market Tracker

06/01 3:06am ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.03
Delayed Data
As of May 31
 +0.135 / +2.76%
Today’s Change
3.61
Today|||52-Week Range
11.15
-18.03%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close4.89
Today’s open4.92
Day’s range4.92 - 5.10
Volume1,326,150
Average volume (3 months)902,897
Market cap$342.0M
Dividend yield--
Data as of 4:00pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+117.41%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book3.78

Competitors

 Today’s
change
Today’s
% change
MYOKMyoKardia Inc-0.21-1.67%
KPTIKaryopharm Therapeut...-0.05-0.52%
SVASinovac Biotech Ltd-0.21-3.45%
AKBAAkebia Therapeutics ...+0.11+1.25%
Data as of 4:00pm ET, 05/31/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.05
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts